Clinical trials
Phase 2 Ischemic Stroke trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 7 |
| 2014 | 3 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 8 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Terminated | 15 |
| Recruiting | 7 |
| Withdrawn | 4 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lumosa Therapeutics Co., Ltd. | 3 |
| University of California, Los Angeles | 3 |
| University of Pennsylvania | 3 |
| Astellas Pharma Inc | 2 |
| Biogen | 2 |
| Mayo Clinic | 2 |
| University of Cincinnati | 2 |
| Wake Forest University Health Sciences | 2 |
| Yale University | 2 |
| ARCA Biopharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 70 |
| Stroke | 35 |
| Thrombosis | 6 |
| Ischemia | 5 |
| Brain Infarction | 3 |
| Brain Diseases | 2 |
| Cerebral Hemorrhage | 2 |
| Cerebral Infarction | 2 |
| Cerebrovascular Disorders | 2 |
| Hemorrhagic Stroke | 2 |
Trials
Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.